Dennison T Veru - Net Worth and Insider Trading
Dennison T Veru Net Worth
The estimated net worth of Dennison T Veru is at least $16,952 dollars as of 2024-11-13. Dennison T Veru is the Director of Fresh Tracks Therapeutics Inc and owns about 22,908 shares of Fresh Tracks Therapeutics Inc (FRTX) stock worth over $16,952. Details can be seen in Dennison T Veru's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dennison T Veru has not made any transactions after 2020-09-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Dennison T Veru
Dennison T Veru Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dennison T Veru owns 3 companies in total, including Fresh Tracks Therapeutics Inc (FRTX) , Anchiano Therapeutics Ltd (CMMB) , and Chemomab Therapeutics Ltd (CMMB) .
Click here to see the complete history of Dennison T Veru’s form 4 insider trades.
Insider Ownership Summary of Dennison T Veru
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FRTX | Fresh Tracks Therapeutics Inc | 2021-06-14 | director |
| CMMB | Anchiano Therapeutics Ltd | 2020-01-01 | director |
| CMMB | Chemomab Therapeutics Ltd | 2020-01-01 | director |
Dennison T Veru Latest Holdings Summary
Dennison T Veru currently owns a total of 1 stock. Dennison T Veru owns 22,908 shares of Fresh Tracks Therapeutics Inc (FRTX) as of September 16, 2020, with a value of $16,952.
Latest Holdings of Dennison T Veru
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FRTX | Fresh Tracks Therapeutics Inc | 2020-09-16 | 22,908 | 0.74 | 16,952 |
Holding Weightings of Dennison T Veru
Dennison T Veru Form 4 Trading Tracker
According to the SEC Form 4 filings, Dennison T Veru has made a total of 1 transactions in Fresh Tracks Therapeutics Inc (FRTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Fresh Tracks Therapeutics Inc is the acquisition of 667 shares on September 16, 2020, which cost Dennison T Veru around $24,300.
Insider Trading History of Dennison T Veru
- 1
Dennison T Veru Trading Performance
GuruFocus tracks the stock performance after each of Dennison T Veru's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dennison T Veru is -15.16%. GuruFocus also compares Dennison T Veru's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dennison T Veru within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Dennison T Veru's insider trading performs compared to the benchmark.
Performance of Dennison T Veru
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 14.74 | | | | | |
| Relative Return to S&P 500(%) | 11.84 | | | | | |
Dennison T Veru Ownership Network
Ownership Network List of Dennison T Veru
Ownership Network Relation of Dennison T Veru
Dennison T Veru Owned Company Details
What does Fresh Tracks Therapeutics Inc do?
Who are the key executives at Fresh Tracks Therapeutics Inc?
Dennison T Veru is the director of Fresh Tracks Therapeutics Inc. Other key executives at Fresh Tracks Therapeutics Inc include Chief Medical Officer Monica E. Luchi , director & CHAIRMAN OF THE BOARD Reginald L Hardy , and General Counsel and CCO David R. Mcavoy .
Fresh Tracks Therapeutics Inc (FRTX) Insider Trades Summary
Over the past 18 months, Dennison T Veru made no insider transaction in Fresh Tracks Therapeutics Inc (FRTX). Other recent insider transactions involving Fresh Tracks Therapeutics Inc (FRTX) include a net sale of 110 shares made by ,
In summary, during the past 3 months, insiders sold 0 shares of Fresh Tracks Therapeutics Inc (FRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 110 shares of Fresh Tracks Therapeutics Inc (FRTX) were sold and 1,086,412 shares were bought by its insiders, resulting in a net purchase of 1,086,302 shares.
Fresh Tracks Therapeutics Inc (FRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fresh Tracks Therapeutics Inc Insider Transactions
Dennison T Veru Mailing Address
Above is the net worth, insider trading, and ownership report for Dennison T Veru. You might contact Dennison T Veru via mailing address: C/o Palidade Capital, One Bridge Plaza North #695, Fort Lee Nj 07024.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
